Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Update Il y a 4 ans
Reference: NCT00665002

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine whether the WT-1 vaccine causes an immune response and is safe. The WT-1 vaccine is made up of protein pieces that the patient's immune system can recognize as abnormal.


Inclusion criteria

  • leukemia

Links